Cargando…

Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a multifaceted clinicopathological syndrome characterised by excessive hepatic lipid accumulation that causes steatosis, excluding alcoholic factors. Platelet-activating factor (PAF), a biologically active lipid transmitter, induces platelet activation up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hang, Shi, Anhua, Wu, Junzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275506/ https://www.ncbi.nlm.nih.gov/pubmed/35837578 http://dx.doi.org/10.2147/DMSO.S367483

Ejemplares similares

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
por: Li, Zhonglin, et al.
Publicado: (2023)

The aspartate aminotransferase-to-platelet ratio and the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B.
Publicado: (2014)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Physical activity as a protective factor for development of non-alcoholic fatty liver in men
por: Pinto, Carla Giuliano de Sá, et al.
Publicado: (2015)

Nanomaterials Respond to Lysosomal Function for Tumor Treatment
por: Tian, Xuexia, et al.
Publicado: (2022)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
por: Guo, Yan, et al.
Publicado: (2023)

Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease
por: Kilciler, Guldem, et al.
Publicado: (2010)

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
por: Huang, Xin-Juan, et al.
Publicado: (2023)

Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2022)

Bioresponsive Functional Phenylboronic Acid-Based Delivery System as an Emerging Platform for Diabetic Therapy
por: Ma, Qiong, et al.
Publicado: (2021)

Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy
por: Ma, Qiong, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
por: Yin, Xunzhe, et al.
Publicado: (2023)

Severity of non-alcoholic fatty liver disease is a risk factor for developing hypertension from prehypertension
por: Song, Qirui, et al.
Publicado: (2023)

Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update
por: Dorairaj, Vicneswarry, et al.
Publicado: (2020)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

OXPHOS-Mediated Induction of NAD(+) Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease
por: Akie, Thomas E., et al.
Publicado: (2015)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy
por: Zhang, Xinxu, et al.
Publicado: (2020)

Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease
por: Chen, Yajie, et al.
Publicado: (2023)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
por: Malnick, Stephen D. H., et al.
Publicado: (2022)

Treatment of non-alcoholic fatty liver disease
por: Tolman, Keith G, et al.
Publicado: (2007)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Autophagy and Non-Alcoholic Fatty Liver Disease
por: Lavallard, Vanessa J., et al.
Publicado: (2014)

Non-Alcoholic Fatty Liver Disease in Children
por: SINGER, CRISTINA, et al.
Publicado: (2014)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Delvin, Edgard, et al.
Publicado: (2015)

Iron and non-alcoholic fatty liver disease
por: Britton, Laurence J, et al.
Publicado: (2016)

Apoptosis and non-alcoholic fatty liver diseases
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Lipidomics in non-alcoholic fatty liver disease
por: Kartsoli, Sofia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qolh6uoe237baam5minobtifi5